{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Recombinant Growth Factor[C530]" in comments (approximate match)
Status:
US Approved Rx
(2018)
Source:
BLA761080
(2018)
Source URL:
First approved in 1991
Source:
BLA103353
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:RINFABATE [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00351767: Phase 2 Interventional Completed Foot Ulcer, Diabetic
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00004215: Phase 2 Interventional Completed Anemia
(1999)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01919164: Phase 2 Interventional Completed Osteoarthritis, Knee
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01217476: Phase 3 Interventional Completed Diabetic Foot Ulcer of Neuropathic Origin
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00323518: Phase 2 Interventional Completed Oral Mucositis
(2006)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Dermaheal Cosmeceutical Mask Pack Plus by YBK Investment, INC
Source URL:
First approved in 2008
Source:
21 CFR 333D
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00464217: Phase 4 Interventional Completed Acute Myeloblastic Leukaemia
(1998)
Source URL:
Class:
PROTEIN
